Digital Therapeutics & Medical Devices for Migraine Market By Type-
Digital Therapeutics & Medical Devices for Migraine Market By Age-Group-
Digital Therapeutics & Medical Devices for Migraine Market By Mode of Action-
Digital Therapeutics & Medical Devices for Migraine Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Digital Therapeutics & Medical Devices for Migraine Market Snapshot
Chapter 4. Global Digital Therapeutics & Medical Devices for Migraine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type, Estimates & Trend Analysis
5.1. By Type, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type:
5.2.1. Arm Device
5.2.2. Neck Device
5.2.3. Head/Forehead Device
5.2.4. Others
Chapter 6. Market Segmentation 2: By Age Group Estimates & Trend Analysis
6.1. By Age Group & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Age Group:
6.2.1. Above 18 Years
6.2.2. Above 12 Years
Chapter 7. Market Segmentation 3: By Mode Of Action Estimates & Trend Analysis
7.1. By Mode Of Action & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Mode Of Action:
7.2.1. Electrical Pulse
7.2.2. Mild Electrical Stimulation
7.2.3. Deep Muscle Treatment
Chapter 8. Digital Therapeutics & Medical Devices for Migraine Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) estimates and forecasts By Type, 2019-2031
8.1.2. North America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) estimates and forecasts By Age Group, 2019-2031
8.1.3. North America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) estimates and forecasts By Mode Of Action, 2019-2031
8.1.4. North America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Type, 2019-2031
8.2.2. Europe Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Age Group, 2019-2031
8.2.3. Europe Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Mode Of Action, 2019-2031
8.2.4. Europe Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Type, 2019-2031
8.3.2. Asia Pacific Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Age Group, 2019-2031
8.3.3. Asia Pacific Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Mode Of Action, 2019-2031
8.3.4. Asia Pacific Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Type, (US$ Million) 2019-2031
8.4.2. Latin America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Age Group, (US$ Million) 2019-2031
8.4.3. Latin America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Mode Of Action, (US$ Million) 2019-2031
8.4.4. Latin America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Type, (US$ Million) 2019-2031
8.5.2. Middle East & Africa Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Age Group, (US$ Million) 2019-2031
8.5.3. Middle East & Africa Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Mode Of Action, (US$ Million) 2019-2031
8.5.4. Middle East & Africa Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Relivion MG
9.2.2. gammaCore
9.2.3. WeatherX
9.2.4. Aculief
9.2.5. Theragun
9.2.6. Allay Lamp
9.2.7. Shakti Mat
9.2.8. Allodynic Therapeutics, LLC
9.2.9. Amgen Inc.
9.2.10. Bayer AG
9.2.11. Cefaly Technology
9.2.12. Cirrus Healthcare Products
9.2.13. electroCore, Inc
9.2.14. Eli Lilly and Company
9.2.15. eNeura Inc.
9.2.16. GlaxoSmithKline plc.
9.2.17. Neurolief Ltd.
9.2.18. Neuros Medical, Inc.
9.2.19. Novartis AG
9.2.20. Pfizer Inc.
9.2.21. Salvia BioElectronics B.V.
9.2.22. Theranica Bio-Electronics Ltd.
9.2.23. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.